← Back to all protocols
8

Upper GI BleedGI

Symptoms

  • Hematemesis or coffee-ground emesis
  • Melena (haematochezia if brisk bleeding)
  • Dizziness, syncope, signs of shock (tachycardia, hypotension) from blood loss
  • History of peptic ulcer disease, varices/chronic liver disease, NSAID/aspirin/anticoagulant use

Investigations

  • Bloods: FBC, U&E, LFT, coagulation screen (incl. fibrinogen), VBG, group & save, amylase; note Hb, platelets, PT/APTT, fibrinogen
  • Initial BP, HR and early warning score; triage shocked and/or actively bleeding patients to resus, others to majors
  • Glasgow-Blatchford Score (total the points):
  • SBP (mmHg): 100–109 = 1; 90–99 = 2; <90 = 3
  • Heart rate >100 = 1; melaena = 1; syncope = 2; hepatic disease = 2; cardiac failure = 2
  • Blood urea (mmol/L): 6.5–7.9 = 2; 8.0–9.9 = 3; 10.0–24.9 = 4; β‰₯25 = 6 (if the lab reports BUN in mg/dL: 18.2–22.3 = 2; 22.4–27.9 = 3; 28–69.9 = 4; β‰₯70 = 6 β€” check which units your lab uses)
  • Haemoglobin (g/L): men 120–129 = 1; women 100–119 = 1; men 100–119 = 3; men or women <100 = 6
  • Score >1 β†’ admit. Score 0–1 with normal bloods and no evidence of active bleeding β†’ consider outpatient pathway (see treatment)
  • Outpatient exclusion criteria (any = admit): other reason for admission, on warfarin/DOAC, known varices, age >70, lives alone, no telephone, active vomiting

Treatment

  • Resuscitation: seek senior help if shocked/actively bleeding; two large-bore IV lines; bloods as above
  • Fluids: balanced crystalloid (e.g. Plasmalyte/Ringer's lactate) while awaiting blood; avoid over-resuscitation
  • Transfusion: restrictive β€” transfuse only if Hb <70 g/L (<80 g/L in unstable coronary artery disease); usual target 70–90 g/L. If shocked/major bleed: cross-match 6 units PRBC or activate massive haemorrhage protocol
  • Anticoagulated patient: offer Prothrombin complex concentrate (PCC) β€” warfarin: 25–50 units/kg guided by INR + vitamin K 5–10mg IV; DOAC: PCC ~50 units/kg or specific reversal (dabigatran: idarucizumab 5g IV)
  • Platelets <50 Γ—10⁹/L: offer platelet transfusion
  • Coagulopathy (bleeding not related to liver disease): fibrinogen <1 g/L, or PT/APTT >1.5Γ— normal β†’ Fresh frozen plasma 15 mL/kg
  • Suspected variceal bleeding: Terlipressin 2mg IV bolus then 1–2mg every 4–6h (up to 2–5 days); if terlipressin unavailable: Octreotide 50 micrograms IV bolus then 50 micrograms/h infusion; antibiotic prophylaxis β€” Ceftriaxone 1g IV daily (up to 7 days) or per local antimicrobial guidelines; urgent endoscopy with band ligation (within 12h); balloon tamponade as a bridge if massive/uncontrolled
  • Acid suppression: do NOT routinely give before endoscopy in suspected non-variceal bleeding (no mortality or transfusion benefit, though it reduces need for endoscopic therapy). Consider if significant endoscopy delay: Pantoprazole 80mg IV. After endoscopic therapy for high-risk ulcer: Pantoprazole 80mg IV bolus then 8mg/h for 72h or 40mg IV every 12h
  • Optional pre-endoscopy prokinetic: Erythromycin 250mg IV 30–120 min before endoscopy to improve gastric visualisation
  • Tranexamic acid: not recommended β€” no benefit shown in UGIB (HALT-IT trial) and increased thrombotic events
  • Endoscopy: refer to the medical/GI on-call for emergent endoscopy immediately after resuscitation if shocked or actively bleeding; otherwise within 24h
  • Low-risk discharge (Blatchford 0–1, normal bloods, no active bleeding, no exclusion criteria): confirm adequate social support and ability to attend outpatient gastroscopy; refer to the urgent low-risk outpatient endoscopy pathway; give strict safety-netting advice; continue low-dose aspirin for secondary vascular prevention; discuss clopidogrel continuation with the relevant specialist and the patient; advise stopping other NSAIDs and review after gastroscopy
← Back to all protocols